| Announce Date | 11/05/2025 |
| EPS Normalized Actual | $1.22 (Beat by $0.03) |
| EPS GAAP Actual | $1.22 (Beat by $0.03) |
| Revenue Actual | $0.175679B |
| Revenue Surprise | Beat by $175.679M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $1.26 |
| EPS GAAP Estimate | $1.26 |
| Revenue Estimate | $0.207133951B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 4.74 | 17.06 | 4.63587 | 4.84096 | 1 |
| Dec 2028 | 4.36 | 18.55 | 4.33814 | 4.38185 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.22 | 0.2 | 0.175679B | 4.1% | -28.73M |
| FQ2 2025 (Jun 2025) | 0.73 | -0.29 | 0.159452B | 8.62% | -18.79M |
| FQ1 2025 (Mar 2025) | 1.14 | 0.13 | 0.21897B | 12.62% | 43.06M |
| FQ4 2024 (Dec 2024) | 0.61 | -0.56 | 0.171415B | 3.95% | 6.85M |
| FQ3 2024 (Sep 2024) | 1.13 | 0.19 | 0.16848B | 4.72% | 16.44M |
| FQ2 2024 (Jun 2024) | 0.66 | -0.68259 | 0.145713B | -1.57% | -135.21M |
| FQ1 2024 (Mar 2024) | 0.93 | 0.93 | 0.191336B | -13.55% | 191.34M |
| FQ4 2023 (Dec 2023) | 0 | 0 | 0.164652B | -15.29% | 164.65M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
1.26
Consensus Revenue Estimates
0.207133951B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0.81 | -- | 0.81 | 0.81 | 1 |
| FQ3 2026 (Sep 2026) | 1.27 | 3.94 | 1.27 | 1.27 | 1 |
| FQ2 2026 (Jun 2026) | 0.84 | 13.1 | 0.84 | 0.84 | 1 |
| FQ1 2026 (Mar 2026) | 1.12 | -1.79 | 1.12 | 1.12 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0.17B | -- | 0.17B | 0.17B | 1 |
| FQ3 2026 (Sep 2026) | 0.24B | 26.77 | 0.24B | 0.24B | 1 |
| FQ2 2026 (Jun 2026) | 0.24B | 32.51 | 0.24B | 0.24B | 1 |
| FQ1 2026 (Mar 2026) | 0.17B | -31.2 | 0.17B | 0.17B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
3
EPS # of in-lines
1
Revenue # of Beats
5
Revenue # of Misses
3
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.02 | 1.22 | 0.2 | 16.39% |
| FQ2 2025 (Jun 2025) | 1.02 | 0.73 | -0.29 | -39.73% |
| FQ1 2025 (Mar 2025) | 1.01 | 1.14 | 0.13 | 11.4% |
| FQ4 2024 (Dec 2024) | 1.17 | 0.61 | -0.56 | -91.8% |
| FQ3 2024 (Sep 2024) | 0.94 | 1.13 | 0.19 | 16.81% |
| FQ2 2024 (Jun 2024) | 1.34259 | 0.66 | -0.68259 | -103.42% |
| FQ1 2024 (Mar 2024) | 0.93 | 0.93 | 100% | |
| FQ4 2023 (Dec 2023) | 0 | 0 | NAN% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.2B | $0.18B | $-28.73M | -16.36% |
| FQ2 2025 (Jun 2025) | $0.18B | $0.16B | $-18.79M | -11.79% |
| FQ1 2025 (Mar 2025) | $0.18B | $0.22B | $43.06M | 19.67% |
| FQ4 2024 (Dec 2024) | $0.16B | $0.17B | $6.85M | 3.99% |
| FQ3 2024 (Sep 2024) | $0.15B | $0.17B | $16.44M | 9.76% |
| FQ2 2024 (Jun 2024) | $0.28B | $0.15B | $-135.21M | -92.79% |
| FQ1 2024 (Mar 2024) | $0B | $0.19B | $191.34M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.16B | $164.65M | 100% |